A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis
article
OA: closed
CC0
⤵ 67 in-corpus citations
Abstract
BACKGROUND: Endometriosis is a common gynaecological problem of uncertain aetiology. It affects primarily young, reproductive-aged women and can result in chronic pelvic pain and infertility. Current approved therapies have significant side-effects and hysterectomy is employed as a final solution. ERB-041 is a selective estrogen receptor-beta (ERbeta) agonist that has anti-inflammatory activity in preclinical models of arthritis and inflammatory bowel disease, but is inactive in many preclinical models of classic estrogen activity. Because endometriosis is now thought to be, at least in part, an inflammatory disease, we evaluated ERB-041's activity in an experimentally induced model of endometriosis. METHODS: Athymic nude mice (ovariectomized or intact) were implanted with tissue fragments of normal human endometrium. After establishment of lesions for 11-14 days, mice were treated with ERB-041 for 15-17 days. Upon euthanasia, the number of lesions, their size and location were noted. Five lesions were recovered for RNA analysis. RESULTS: Across six studies, ERB-041 caused complete lesion regression in 40-75% of the mice studied. The compound appeared to be equally effective in gonad-intact as in ovariectomized mice, and analysed recovered lesions expressed ERalpha but not ERbeta mRNA. CONCLUSIONS: ERB-041 and possibly other ERbeta selective agonists may be a useful new approach to treating endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Matrix Metalloproteinases and Endometriosis via openalex
- Medical Management of Endometriosis: Novel Targets and Approaches towards the Development of Future Treatment Regimes via openalex
- Modern combined oral contraceptives for pain associated with endometriosis via openalex
- Pathogenesis of Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal endometriosis: validation of an in-vivo model via openalex
- Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis via openalex
- Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2070907292 via openalex
- W2073353512 via openalex
- W2073883348 via openalex
- W2085798593 via openalex
- W2119763663 via openalex
- W2121475182 via openalex
- W2139900098 via openalex
- W2155274896 via openalex
- W2159089057 via openalex
- W2165730820 via openalex
- W4313310174 via openalex
- W141728048 via openalex
- W1555149618 via openalex
- W1874568289 via openalex
- W1967004474 via openalex
- W1981306061 via openalex
- W1986371906 via openalex
- W2019105055 via openalex
- W2032946628 via openalex
- W2039520335 via openalex
- W2054267961 via openalex
- W2065088050 via openalex
Cited by (50)
- Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility 2025
- Immunologic Aspects of Endometriosis 2024
- Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Alpha-Lipoic Acid Plays a Role in Endometriosis: New Evidence on Inflammasome-Mediated Interleukin Production, Cellular Adhesion and Invasion 2021
- Lipoxin A4 inhibits the development of endometriosis in a mouse model by suppressing local estradiol synthesis 2020
- Identifying Mechanisms of Endometriosis-Associated Reduced Fecundity in a Rat Model: Novel Insights toward Understanding Human Infertility 2020
- Local estrogen formation and its regulation in endometriosis 2019
- Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways 2018
- Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues 2018
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Dysfunctional signaling underlying endometriosis: current state of knowledge 2018
- Estrogen is essential but not sufficient to induce endometriosis 2017
- Reversal of fortune: estrogen receptor-β in endometriosis 2016
- Potential role of estrogen in maintaining the imbalanced sympathetic and sensory innervation in endometriosis 2016
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model 2016
- Surgery for Benign Gynecological Disorders Improve Endometrium Receptivity: A Systematic Review of the Literature 2016
- Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways 2015
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis 2015
- Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis 2015
- Pathological functions of hypoxia in endometriosis 2015
- Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis 2015
- Emerging treatment of endometriosis 2015
- Experimental Treatments of Endometriosis 2015
- The effect of macrophages on fibroblast activity and lesion development in mouse models of endometriosis. 2014
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis 2014
- Estrogen Receptor (ER) Agonists Differentially Regulate Neuroangiogenesis in Peritoneal Endometriosis via the Repellent Factor SLIT3 2014
- Preliminary Study of Quercetin Affecting the Hypothalamic‐Pituitary‐Gonadal Axis on Rat Endometriosis Model 2014
- Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells 2014
- Estrogen receptor β agonist inhibits proliferation of endometrial stromal cells in an estrogen-receptor independent manner 2014
- Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy 2013
- Endometriosis 2013
- A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis 2012
- Hepatic endometrioma: a case report and review of the literature: report of a case 2012
- The role of NF-kappaB in endometriosis 2012
- Role of Estrogen Receptor Signaling Required for Endometriosis-Like Lesion Establishment in a Mouse Model 2012
- Models of Endometriosis: Animal Models I – Rodent‐Based Chimeric Models 2011
- Novel Therapies Targeting Endometriosis 2011
- Role of Steroid Hormones: Estrogen and Endometriosis 2011
- Estrogen biosynthesis and signaling in endometriosis 2011
- Estrogen metabolism and action in endometriosis 2009
- Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor α in rat uterine cells and tissues 2009
- New Developments in Medical Management of Endometriosis 2009
- Endometriosis in Italy: From cost estimates to new medical treatment 2009
- Endometriosis 2009
- Endometriosis 2009
- ERB-041, a selective ERβ agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-κB activation 2009
- Treatment strategies for endometriosis 2008
- Development and evaluation of two mouse models for endometriosis focused on the involvement of the immune system in endometriosis establishment 2008
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:26.305326+00:00
License: CC0
· commercial use OK